Aptevo Therapeutics Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Dec 2014 | — | — | $3.6M |
| Jun 2015 | — | — | $4.1M |
| Sep 2015 | — | — | $3.5M |
| Dec 2015 | $39.1M | $127.8M | $4.6M |
| Mar 2016 | $38.1M | $127.9M | $3.1M |
| Jun 2016 | $36.3M | $133.5M | $5.5M |
| Sep 2016 | $36.9M | $100.6M | $10.9M |
| Dec 2016 | $41.3M | $91.9M | $9.7M |
| Mar 2017 | $36.3M | $97.8M | $14.0M |
| Jun 2017 | $35.5M | $86.9M | $22.3M |
| Sep 2017 | $40.7M | $131.0M | $75.8M |
| Dec 2017 | $35.0M | $117.0M | $7.1M |
| Mar 2018 | $31.8M | $100.2M | $11.8M |
| Jun 2018 | $34.0M | $90.0M | $7.2M |
| Sep 2018 | $34.9M | $78.9M | $28.4M |
| Dec 2018 | $37.1M | $67.5M | $30.6M |
| Mar 2019 | $41.7M | $80.8M | $37.0M |
| Jun 2019 | $39.9M | $66.1M | $21.0M |
| Sep 2019 | $40.8M | $60.6M | $17.7M |
| Dec 2019 | $41.6M | $53.4M | $12.4M |
| Mar 2020 | $10.1M | $25.2M | $12.3M |
| Jun 2020 | $9.9M | $18.5M | $7.6M |
| Sep 2020 | $35.2M | $37.4M | $24.9M |
| Dec 2020 | $37.0M | $53.5M | $40.0M |
| Mar 2021 | $58.2M | $68.8M | $57.5M |
| Jun 2021 | $57.6M | $71.5M | $60.4M |
| Sep 2021 | $56.7M | $64.0M | $52.1M |
| Dec 2021 | $55.4M | $56.6M | $45.0M |
| Mar 2022 | $51.1M | $45.2M | $35.0M |
| Jun 2022 | $15.8M | $38.8M | $29.4M |
| Sep 2022 | $15.9M | $31.7M | $22.2M |
| Dec 2022 | $16.2M | $34.2M | $22.6M |
| Mar 2023 | $11.7M | $35.0M | $25.3M |
| Jun 2023 | $12.7M | $28.9M | $21.0M |
| Sep 2023 | $12.4M | $27.1M | $19.1M |
| Dec 2023 | $12.6M | $24.8M | $16.9M |
| Mar 2024 | $11.5M | $17.6M | $10.3M |
| Jun 2024 | $10.5M | $14.9M | $8.1M |
| Sep 2024 | $10.7M | $15.1M | $7.8M |
| Dec 2024 | $10.8M | $15.6M | $8.7M |
| Mar 2025 | $9.8M | $8.3M | $2.1M |
| Jun 2025 | $9.1M | $15.6M | $9.4M |
| Sep 2025 | $9.6M | $27.0M | $21.1M |
| Dec 2025 | $9.8M | $27.2M | $21.6M |
| Mar 2026 | $8.3M | $19.9M | $14.5M |
| Jun 2026 | $8.5M | $14.5M | $9.8M |